Company: MYSEW
Filing Date: 2025-11-26
Form Type: S-3
Source: 0001213900-25-115502
Chunk: 16

Company: Myseum, Inc.
Filing Date: 2025-11-26
Form: S-3
Chunk 16
---
 of any of these known or unknown risks might cause you to lose all or part of your investment
in the offered securities.

<div align='center'>-6-

FORWARD-LOOKING STATEMENTS</div>

This prospectus and
any accompanying prospectus supplement, including the documents that we incorporate by reference, contains forward-looking statements
within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended
(the “Exchange Act”). Any statements in this prospectus and any accompanying prospectus supplement about our expectations,
beliefs, plans, objectives, assumptions or future events or performance are not historical facts and are forward-looking statements.
These statements are often, but not always, made through the use of words or phrases such as “believe,” “will,”
“expect,” “anticipate,” “estimate,” “intend,” “plan,” and “would.”
For example, statements concerning financial condition, possible or assumed future results of operations, growth opportunities, industry
ranking, plans and objectives of management, markets for our common stock and future management and organizational structure are all
forward-looking statements. Forward-looking statements are not guarantees of performance. They involve known and unknown risks, uncertainties
and assumptions that may cause actual results, levels of activity, performance or achievements to differ materially from any results,
levels of activity, performance or achievements expressed or implied by any forward-looking statement.

Any forward-looking
statements are qualified in their entirety by reference to the risk factors discussed throughout this prospectus and any accompanying
prospectus supplement. Some of the risks, uncertainties and assumptions that could cause actual results to differ materially from estimates
or projections contained in the forward-looking statements include, but are not limited to:

| ● | our business strategies;                                                                           |
| ● | the timing of regulatory submissions;                                                              |
| ● | our ability to obtain and maintain regulatory approval of our existing product candidates and any  
 other product candidates we may develop, and the labeling under any approval we may obtain;        |
| ● | risks relating to the timing and costs of clinical trials, the timing and costs of other expenses; |
| ● | risks related to market acceptance of products;                                                    |

| ● | intellectual property risks;                                     |
| ● | risks associated with our reliance on third party organizations; |
| ● | our competitive position;                                        |
| ● | our industry environment;                                        |

<div align='center'>-7-</div>

| ● | our anticipated financial and operating